← Back to Search

Clinical Decision Support Tool for Heart Failure

N/A
Recruiting
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a tool to help pharmacists improve adherence to medical guidelines and evaluate its effectiveness. #REAIM

Who is the study for?
This trial is for pharmacists working at Northwestern Medicine in the Medication Adjusted to Target (MAT) Clinic. There are no specific exclusion criteria, so all pharmacists in this setting are eligible to participate.
What is being tested?
The study is testing a new tool that helps pharmacists improve treatment adherence in heart failure patients by following medical guidelines more closely. The success of the tool will be measured using the RE-AIM framework.
What are the potential side effects?
Since this trial involves a clinical decision support tool rather than a medication or therapy, there are no direct side effects associated with its use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Reach
Secondary study objectives
Adoption
Implementation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Active clinical decision support tool for pharmacistsExperimental Treatment1 Intervention
In this single arm, pilot feasibility study, pharmacists with be exposed to a clinical decision support tool to facilitate monitoring adherence to GDMT for patients with heart failure with reduced ejection fraction

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,647 Previous Clinical Trials
958,647 Total Patients Enrolled
~3 spots leftby Jun 2025